Aerie Pharmaceuticals
Data Breaches, Cyber Attacks and Security Report

https://aeriepharma.com  ᛫ 
Last updated November 16, 2019

About Aerie Pharmaceuticals

Company Overview

Aerie Pharmaceuticals Inc. (NASDAQ: AERI) is a publicly traded, clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.

Valuation

Employees

CEO

Location

Data Breaches and Security News

Aerie Pharmaceuticals Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Aerie Pharmaceuticals is implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for Aerie Pharmaceuticals

Get full security report ›

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare Aerie Pharmaceuticals's security performance with other companies